IVD Medical Holding (HKSE:01931) Debt-to-EBITDA : 0.92 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

IVD Medical Holding's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$377 Mil. IVD Medical Holding's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$0 Mil. IVD Medical Holding's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$408 Mil. IVD Medical Holding's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.92.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for IVD Medical Holding's Debt-to-EBITDA or its related term are showing as below:

HKSE:01931' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.82 Med: 1 Max: 1.44
Current: 0.96

During the past 8 years, the highest Debt-to-EBITDA Ratio of IVD Medical Holding was 1.44. The lowest was 0.82. And the median was 1.00.

HKSE:01931's Debt-to-EBITDA is ranked better than
64% of 75 companies
in the Medical Distribution industry
Industry Median: 2 vs HKSE:01931: 0.96

IVD Medical Holding Debt-to-EBITDA Historical Data

The historical data trend for IVD Medical Holding's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Debt-to-EBITDA Chart

IVD Medical Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

0.82

1.44

1.31

1.00

0.87

IVD Medical Holding Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial									1.33	3.19	0.88	1.49	0.92

Competitive Comparison of IVD Medical Holding's Debt-to-EBITDA

For the Medical Distribution subindustry, IVD Medical Holding's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IVD Medical Holding's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, IVD Medical Holding's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where IVD Medical Holding's Debt-to-EBITDA falls into.

IVD Medical Holding Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

IVD Medical Holding's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(376.611	+	0)	/	435.245
	=	0.87

IVD Medical Holding's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(376.611	+	0)	/	408.462
	=	0.92

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

IVD Medical Holding (HKSE:01931) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

IVD Medical Holding Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

IVD Medical Holding (HKSE:01931) Headlines

No Headlines